Latest News

 Filter by Provider

Cardano could be headed for a big comeback in 2027.

Tesla's third-quarter show the company is still struggling to grow.

Believing in a Bitcoin supercycle doesn't really change how to invest in it.

Here's how pharmaceutical stocks compare to biotech in terms of risk, rewards, and costs.

United Rentals’ third quarter results were driven by sustained momentum in large-scale projects across multiple end markets, supported by the company’s broad...

Wyndham’s third quarter results met Wall Street’s revenue expectations, but the market response was negative, with shares declining following the release. Ma...

Pinnacle Financial Partners delivered a third quarter that saw positive market reception, as revenue and adjusted EPS both outpaced Wall Street expectations....

Graco’s third quarter was met with a significant negative market reaction, as both revenue and non-GAAP profit missed Wall Street’s expectations. Management ...

Globe Life’s third quarter saw solid revenue growth, yet the market responded negatively after adjusted earnings came in below analyst expectations. Manageme...

First American Financial’s third quarter was shaped by contrasting trends across its core business lines. Management noted that commercial title services con...

Professional tools and equipment manufacturer Snap-on (NYSE:SNA) fell short of the market’s revenue expectations in Q3 2026, with sales flat year on year at ...

Enterprise Financial Services delivered third-quarter results that were broadly in line with Wall Street’s revenue expectations, but missed on non-GAAP profi...

Fulton Financial’s third quarter results were met with a positive market reaction, driven by notable growth in both revenue and non-GAAP profit. Management a...

Manufacturing company Dover (NYSE:DOV) beat Wall Street’s revenue expectations in Q3 2026, with sales up 7.5% year on year to $2.23 billion. Its non-GAAP pro...

Cloud communications provider RingCentral (NYSE:RNG) announced better-than-expected revenue in Q3 2026, with sales up 5.9% year on year to $676 million. Guid...

Leading data storage manufacturer Western Digital (NASDAQ: WDC) reported revenue ahead of Wall Street’s expectations in calendar Q3 2026 (fiscal Q1 2027), wi...

Packaging Corporation of America’s Q3 results were met with a positive market response, reflecting robust year-on-year sales growth and solid operational exe...

Stewart Information Services’ third quarter was marked by ongoing challenges in the residential housing market, which management attributed primarily to a ra...

Oceaneering’s third quarter results drew a sharp negative market reaction, with shares falling significantly following the announcement. Management pointed t...

Waste Connections delivered Q3 results that exceeded Wall Street’s revenue and non-GAAP profit expectations, with management highlighting the benefits of cor...

Rollins’ third quarter results drew a positive market response despite missing Wall Street’s revenue expectations, as management addressed the core challenge...

On a day when the Nasdaq plunged, housing stocks were surprising winners.

Forget the quantum computing pure plays -- Microsoft is in a unique position in this space.

Executives from Healios and SAB Biotherapeutics (NASDAQ:SABS) outlined their approaches to developing scalable biologic therapies during a Chardan discussion focused on complex treatments designed for commercial manufacturing. Healios Chief Financial Officer Rich Kincaid discussed the company’s mul

Architectural specifications and the adoption of electronic locks create multiyear revenue visibility that pricing discipline alone cannot explain.

Both companies are experiencing sales growth but also substantial losses.

Cancellations now stem from clinical failures rather than funding shortages, signaling a healthier market for contract research.

Margin gains from internal brewing are offsetting volume declines, but new high-margin brands will determine if that cushion holds.

The EV maker's operating profit recovered last quarter. But was a one-off bump behind it?

Sun Cruiser surges 60% as gross margins hit highest level since 2017.

Record adjusted net income and improved cost guidance signal production growth ahead.

Management's refusal to chase loan volume with looser terms is the real test of whether cost discipline can sustain earnings growth.

Operational efficiency gains are offsetting cost inflation, underpinning the company's ability to sustain margin expansion.

The beverage and snacks titan has been the fast-food purveyor's exclusive beverage partner for decades.

Production ramps create near-term cost pressure, but management sees a clear path to 18% operating margins by decade's end.

Media revenue jumped over 10% as synergy gains drive margin expansion.

HOKA and UGG drive record revenue despite promotional headwinds and logistics disruptions.

Revenue surged 55% as cloud storage demand and AI infrastructure investments accelerated.

The company is converting capital markets infrastructure into high-margin recurring revenue, a structural shift that insulates profitability from trading volatility.

Prelude Therapeutics (NASDAQ:PRLD) outlined progress across three priority programs at a Chardan Capital investor session, emphasizing its recently initiated JAK2 program, an IND-cleared KAT6A degrader for breast cancer and a mutant calreticulin, or mCALR, program for myeloproliferative neoplasms.

Cost discipline and moderating capital spending are freeing up cash flow for shareholder returns.

Pricing power and operational discipline held margins steady even as sales flatlined, signaling resilience beyond the current channel turbulence.

Higher charge-offs and lower earnings guidance offset the strategic wins from new funding partnerships and loan retention.

Wood's Ark Invest is building back its exposure to Netflix.

Management closed nine branches to boost annual pre-tax income by $2.3M–$2.7M.

A $1.4 billion cost headwind this year tests whether innovation-backed pricing can sustain margin protection without sacrificing volume.

Mullen Group (TSE:MTL) said its third-quarter operating performance was among its strongest to date, citing the resilience of its diversified business model, a strong balance sheet and improving returns in selected industrial markets. Management also said it remains cautious about committing capital

Xtract One Technologies (TSE:XTRA) reported record fiscal 2026 revenue as demand grew for its security-screening products across education, healthcare, commercial and entertainment markets, while operating expenses rose at a slower rate than sales. For the year, revenue increased 108% to C$28.8 mil

Ermenegildo Zegna (NYSE:ZGN) reported third-quarter 2026 revenue of €434 million, up 8% organically from the prior-year period, as direct-to-consumer growth across all regions offset pressure in parts of its wholesale operations and a more difficult consumer backdrop in Greater China for Thom Browne

Waste Connections (NYSE:WCN) reported third-quarter results that exceeded its expectations and raised its full-year 2026 outlook, citing pricing gains, improving landfill activity, acquisition contributions and commodity-related revenue growth. Third-quarter revenue rose 7.3% from a year earlier to